ANIX
Anixa Biosciences (ANIX)
$27
About Anixa Biosciences (ANIX)
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Details
Daily high
$3.62
Daily low
$3.21
Price at open
$3.60
52 Week High
$5.46
52 Week Low
$2.07
Market cap
117.5M
Dividend yield
0.00%
Volume
645,736
Avg. volume
507,939
P/E ratio
-10.36
Anixa Biosciences News
Details
Daily high
$3.62
Daily low
$3.21
Price at open
$3.60
52 Week High
$5.46
52 Week Low
$2.07
Market cap
117.5M
Dividend yield
0.00%
Volume
645,736
Avg. volume
507,939
P/E ratio
-10.36